All 'p38β MAPK' Products



6 Item(s)

per page

Set Descending Direction
Catalog No. Product Name Application Product Information
A12526

Losmapimod

Pan-PIM kinase inhibitor
Losmapimod, also know as GW856553 or GW856553X, is a drug developed by GlaxoSmithKline which acts as a selective inhibitor of the enzyme family known as p38 mitogen-activated protein kinases.
A13551

Pamapimod (R-1503)

p38 MAPK inhibitor
Pamapimod is a novel p38 mitogen-activated protein kinase inhibitor.
A11078

PH-797804

p38 MAPK inhibitor
PH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
A10823

SB 202190

p38 MAPK Inhibitor
SB202190 is a highly selective, potent and cell-permeable inhibitor of p38 MAP kinase.
A11562

SB 239063

p38 MAPK inhibitor
SB 239063 is a potent and selective p38 MAP kinase inhibitor (IC50 = 44 nM for p38α). SB 239063 displays > 220-fold selectivity over ERK, JNK1 and other kinases; ~ 3-fold more selective than SB 203580. SB 239063 reduces inflammatory cytokine production and is neuroprotective following oral administration in vivo.
A10983

VX-745

p38 MAPK inhibitor
VX-745 is a small-molecule inhibitor of MAPK that is reported to be active against several isotypes of p38 MAPK, including p38α, p38βand p38γ .

6 Item(s)

per page

Set Descending Direction